✦ LIBER ✦

Pegfilgrastim versus filgrastim to accelerate hematopoietic recovery after high-dose melphalan and autologous hematopoietic stem cell transplantation (ASCT) for multiple myeloma

✍ Scribed by R.L. Olin; S.M. Luger; D.L. Porter; S.J. Schuster; D. Tsai; S. Nasta; A. Perl; A.W. Loren; S. Goldstein; P. Mangan; V. Sherry; K. Cunningham; B. Sachs; K. Hummel; E.A. Stadtmauer

Book ID: 116278213
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 56 KB
Volume: 11
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2004.12.257

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pegfilgrastim compared with filgrastim a

Pegfilgrastim compared with filgrastim after high-dose melphalan and autologous hematopoietic peripheral blood stem cell transplantation in multiple myeloma patients

✍ Massimo Martino; Giulia Praticò; Giuseppe Messina; Giuseppe Irrera; Elisabetta M 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 139 KB

Comparison of fixed dose (6 mg) pegfilgr

Comparison of fixed dose (6 mg) pegfilgrastim and daily filgrastim to accelerate hemopoietic recovery after autologous stem cell transplantation (ASCT)

✍ G. Marcacci; M.C. Petti; F. Ferrara; N. Scarpato; S. Storti; G. D’Arena; F. Palo 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 64 KB

Early versus late administration of pegf

Early versus late administration of pegfilgrastim after high-dose chemotherapy and autologous hematopoietic stem cell transplantation

✍ C. Kahl; H. G. Sayer; A. Hinke; M. Freund; J. Casper 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 303 KB

19: Arsenic trioxide with ascorbic acid

19: Arsenic trioxide with ascorbic acid and high-dose melphalan for autologous hematopoietic stem cell transplantation for multiple myeloma

✍ M.H. Qazilbash; S. Jindani; Z. Gul; R. Saliba; C. Hosing; F. Mendoza; S.P. Qures 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 68 KB

Timing of High Dose Melphalan (HDM) and

Timing of High Dose Melphalan (HDM) and Outcomes for Autologous Stem Cell Transplantation (ASCT) in Patients With Multiple Myeloma (MM)

✍ A. Mahindra; B. Bolwell; L. Rybicki; R. Sobecks; B. Pohlman; S. Andresen; M. Ear 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 75 KB

PCN60 COST-EFFECTIVENESS OF PEGFILGRASTI

PCN60 COST-EFFECTIVENESS OF PEGFILGRASTIM VERSUS FILGRASTIM AFTER HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS STEM CELL TRANSPLANTATION IN PATIENTS WITH LYMPHOMA AND MYELOMA

✍ L. Perrier; A. Lefranc; P. Quittet; P. Moreau; C. Siani; H. Ghesquières; F. Jard 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB